Objectives: Reepot® is the world’s first target laser based on Q-switch 532nm, and control the hemoglobin chromophore that is related to side effects through a super-cooling control device by VSLS® technology

Introduction: In real-world clinical practice, selective photothermolysis (SPTL) is a relative theory because lasers are absorbed not only by the target chromophore but also by non-target chromophores, which can cause unwanted tissue reactions. These reactions are primarily due to an inflammatory response, which involves locally distributed cells. However, in reality, damage to the capillary loops located in the papillary dermis can result in vascular hemorrhage, migration of inflammatory cells, and persistent and systemic inflammatory responses by these migrated cells.

Materials / method: Vasculature Salvage Laser Surgery® is a combination of technologies that apply the theories and concepts explained above. Reepot® is the first q- switched 532nm laser to which VSLS® is applied. VSLS® system actively controls non-target chromophore through cryophotothermolysis® and a lesion recognition algorithm named Autoderm® in the aid of augmented reality head-mount apparatus.

Results: Complete clinical remission was observed in all cases of solar lentigo during follow-up. In cases where suspicious dermal melanophages were present, we performed additional treatment using q-switched lasers or alexandrite lasers rather than Reepot®.

Conclusion: With the the Reepot® Laser, the treatment frequency is expected to be greatly reduced while also minimizing side effects in the treatment of various pigmentation disorders, including solar lentigo, which are common but could be difficult to treat.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否
请注明名称（个人，公司，学会等等）: Medicare, Ilooda

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： Ilooda and Medicare